Andrew Huberman· PhD
And there were some people that I was just talking to on the cutting edge of this, and their doctors are trying them on this drug instead of the statin.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And there were some people that I was just talking to on the cutting edge of this, and their doctors are trying them on this drug instead of the statin.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the mechanism is a little bit more benign but then they do lower cholesterol a bit more strongly I think than the statins do so then it's like is there like with the really strong cholesterol lowering risk are you increasing some of these other risks